sequencing

  • Home
  • Tag: sequencing
  • Page 3

Evolution of MinION Technology in Microbiology: ASM Microbe 2024 Session Insights by Joshua Quick

Today, I watched the beginning of an Oxford Nanopore Technologies special recording. The title is “Celebrating a decade of DNA discoveries: 10 years of the MinION in microbiology.” This session was from June 14th, 2024, at the ASM Microbe meeting. Pomeranz began by introducing the ONT and noting that there have been over 13,000 publications […]
Read more

Long-read Sequencing and Structural Variants in Precision Oncology

“Accelerating precision oncology research with nanopore sequencing” is the name of the session I watched tonight. Anna Dysko, Associate Director of Business Development with Oxford Nanopore Technologies, facilitated the discussion on April 8, 2024. Dysko explained how nanopore sequencing works: DNA or RNA is passed through a nanopore thanks to the action of a motor […]
Read more

Genomics England and ONT

I continued watching a longer session from Oxford Nanopore Technologies (ONT) summer programming tonight. “The era of complete genomes, at any scale” was the title of a session Cora Vaher gave. They talked about how methylation can be detected without additional library preparation. Haplotype-specific methylation could be very useful in learning about genetic diseases. Vaher shared a […]
Read more

Next-Generation Sequencing for Tuberculosis Detection: Insights from Findx Scientist

Tonight, I watched a recording on the ONT YouTube channel. Swapna Uplekar, a Principal Scientist in Genomics and Sequencing at Findx presented the session, “Targeted next-generation sequencing for drug-resistant tuberculosis detection.”Uplekar works at Findx to use next-generation sequencing to develop diagnostics for diseases globally. Tuberculosis, Uplekar emphasized, remains the top killer, worsened by COVID-19. Drug-resistant cases often remain […]
Read more

Enhancing Biopharmaceutical Safety Through Sequencing

Thomas R. Kreil from Takeda Austria presented at London Calling 2024. The session title was “Pathogen safety in biopharma: sequencing to come.” Kreil began by noting that they do not want to detect viruses in biopharmaceuticals. For this, they use Adventitious Agent Testing (AAT): they search for cytopathic effects on cells. However, current methods are […]
Read more

KeyGene’s Innovative Approach to Banana Pangenome Research

Alexander Wittenberg from KeyGene in the Netherlands spoke at London Calling 2024 about “Unlocking the banana pangenome: harnessing genetic diversity.” They explained that the genetic diversity of bananas is very low because of the passaging of a single clone. Fusarium wilt and black Sigatoka cause disease and elicit the spraying of large amounts of pesticides. […]
Read more

Detecting RNA Modifications with Nanopore Devices and IVT Reference Method

Logan Mulroney from the EMBL-EBI & Center for Genomic Science at the Italian Institute of Technology in Italy presented at London Calling 2024 “A survey of human RNA modifications by direct RNA nanopore sequencing.” Mulroney described RNA modifications as “chemical alterations to canonical nucleotides” and mentioned that they have been implicated in diseases such as […]
Read more

Genome Assembly Challenge: Sequencing Variants of Feline Coronavirus in Cyprus

Amanda Warr from The Roslin Institute in the UK presented at London Calling 2024 on “What the cat dragged in: emergence of a highly pathogenic feline/canine recombinant coronavirus.” Warr explained that feline coronavirus (FCoV) is common. In a subset of cases, it mutates once in the cat host. This is called feline infectious peritonitis (FIP). […]
Read more

Conservation Genomics and Biodiversity Crisis: Insights from Org.one Program | London Calling 2024

The Org. One program is fascinating. I would love to be involved. Tonight, I watched the London Calling 2024 session titled “Org.one to 10.” Kara Dicks, Program Manager at Conservation Genomics with Org.one, spoke about the biodiversity crisis. The Org.one program supports local sequencing. The program has supported over ninety projects. Participants receive kits and […]
Read more

Oxford Nanopore Technologies Innovations for Rapid Tumor Classification – London Calling 2024

The London Calling 2024 studio interview session I watched tonight was about rapid tumor classification. Zoe McDougall spoke to Simon Paine from Nottingham University Hospitals NHS Trust in the UK. Paine is a neuropathologist and analyzes samples to predict patient outcomes. They are excited about discovering ways to classify tumors using Oxford Nanopore Technologies. The […]
Read more
Press ESC key to close search